Website Development Services
Your Company Deserves a Website That Works Like Funding Collateral
Once your company is formed, your next strategic milestone isn’t just being online — it’s being understood, trusted, and acted upon by grant reviewers, accelerators, investors, partners, and early collaborators.
Your initial website must do three critical jobs:
- Establish scientific and institutional credibility
- Signal commercial readiness
- Move the right people to action without oversharing IP
Too many founder websites fail at one or more of these — and that directly costs you funding momentum.
Professional Websites Without Venture Costs
I’ve partnered with Telegenic Marketing, a results-driven web design and digital marketing agency, to deliver high-quality, performance-focused biotech websites without venture-stage pricing.
These sites are built to:
- Clearly communicate your value
- Support grant and accelerator applications
- Convert investor and partner interest
- Be easily updated as validation progresses
This is strategic web development — not a generic template.
Why This Matters for Biotech Founders
Your website becomes funding collateral before you ever raise dollars.
It plays a role in:
- SBIR/STTR grant reviews
- State and federal competitions
- Accelerator and incubator applications
- Friends & family and angel pitches
- Investor first impressions
If someone Googles your company, your website should reinforce — not undermine — credibility.
What You Get With the $3,500 Package
- Custom homepage optimized for clarity, credibility, and conversion
- Core pages: About, Technology Overview, Use Cases, Contact, Funding/Partners
- SEO fundamentals for discoverability
- Lead capture for investor and collaborator inquiries
- Mobile-friendly, professional layout
- Easy future updates and inexpensive revisions
Telegenic builds it.
Bootstrap Your Biotech ensures the messaging works for funding audiences.
Founder Pricing
$3,500 — One-time fee
$35/month hosting fee
No retainers.
No surprise fees.
Bottom Line
Your website isn’t a formality — it’s a strategic asset.
Built correctly, it strengthens grants, improves investor confidence, and accelerates fundraising momentum.
